Show simple item record

dc.contributor.authorHernánndez Benite, Reyna
dc.contributor.authorMartínez Martínez, Llanos
dc.contributor.authorLajara Blesa, Jerónimo
dc.contributor.authorMagistretti, Pierre
dc.contributor.authorMontserrat, Núria
dc.contributor.authorIzpisua Belmonte, Juan Carlos
dc.date.accessioned2024-02-09T14:19:59Z
dc.date.available2024-02-09T14:19:59Z
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/10952/7308
dc.description.abstractCardiovascular disease (CVD) is still the leading cause of death worldwide, but the knowledge and technologies for counteracting this disease may already be in our hands. Scientific advances over the past few years, such as the isolation and differentiation of induced pluripotent stem cells, and the development of gene-editing tools, have enabled us to model CVD, but more importantly, may represent tools for CVD early diagnosis, patient stratification, and treatment.es
dc.language.isoenes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleAt the heart of genome editing and cardiovascular diseaseses
dc.typearticlees
dc.rights.accessRightsopenAccesses
dc.journal.titleCirculation Researches
dc.volume.number123: 221-223es
dc.description.disciplineMedicinaes
dc.identifier.doi10.1161/CIRCRESAHA.118.312676es


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional